Type 2 alveolar epithelial cells (AT2s), facultative progenitor cells of the lung alveolus, play a vital role in the biology of the distal lung. In vitro model systems that incorporate human cells, recapitulate the biology of primary AT2s, and interface with the outside environment could serve as useful tools to elucidate functional characteristics of AT2s in homeostasis and disease. We and others recently adapted human induced pluripotent stem cell–derived AT2s (iAT2s) for air-liquid interface (ALI) culture. Here, we comprehensively characterize the effects of ALI culture on iAT2s and benchmark their transcriptional profile relative to both freshly sorted and cultured primary human fetal and adult AT2s. We find that iAT2s cultured at ALI maintain an AT2 phenotype while upregulating expression of transcripts associated with AT2 maturation. We then leverage this platform to assay the effects of exposure to clinically significant, inhaled toxicants including cigarette smoke and electronic cigarette vapor.
Kristine M. Abo, Julio Sainz de Aja, Jonathan Lindstrom-Vautrin, Konstantinos-Dionysios Alysandratos, Alexsia Richards, Carolina Garcia-de-Alba, Jessie Huang, Olivia T. Hix, Rhiannon B. Werder, Esther Bullitt, Anne Hinds, Isaac Falconer, Carlos Villacorta-Martin, Rudolf Jaenisch, Carla F. Kim, Darrell N. Kotton, Andrew A. Wilson
Title and authors | Publication | Year |
---|---|---|
A stem cell-derived model of human alveolar type 2 cell dysfunction caused by ABCA3 mutations
Yuliang Sun, Hillary Heins, Ping Yang, Carlos Villacorta-Martin, Julian Kwan, Jyn-Chang Jean, Krithi Gopalan, Andrew Emili, F. Cole, Jennifer Wambach, Darrell Kotton |
Journal of Clinical Investigation | 2024 |
Development of an in vitro human alveolar epithelial air-liquid interface model using a small molecule inhibitor cocktail
Tanabe I, Ishimori K, Ishikawa S |
2024 | |
Limited oxygen in standard cell culture alters metabolism and function of differentiated cells.
Tan J, Virtue S, Norris DM, Conway OJ, Yang M, Bidault G, Gribben C, Lugtu F, Kamzolas I, Krycer JR, Mills RJ, Liang L, Pereira C, Dale M, Shun-Shion AS, Baird HJ, Horscroft JA, Sowton AP, Ma M, Carobbio S, Petsalaki E, Murray AJ, Gershlick DC, Nathan JA, Hudson JE, Vallier L, Fisher-Wellman KH, Frezza C, Vidal-Puig A, Fazakerley DJ |
The EMBO Journal | 2024 |
Generation of human alveolar epithelial type I cells from pluripotent stem cells.
Burgess CL, Huang J, Bawa PS, Alysandratos KD, Minakin K, Ayers LJ, Morley MP, Babu A, Villacorta-Martin C, Yampolskaya M, Hinds A, Thapa BR, Wang F, Matschulat A, Mehta P, Morrisey EE, Varelas X, Kotton DN |
Cell Stem Cell | 2024 |
Guidelines for Manufacturing and Application of Organoids: Lung
Lim K, Lee MO, Choi J, Kim JH, Kim EM, Woo CG, Chung C, Cho YH, Hong SH, Cho YJ, Ahn SJ |
International journal of stem cells | 2024 |
Enabling non-viral DNA delivery using lipid nanoparticles co-loaded with endogenous anti-inflammatory lipids
Patel MN, Tiwari S, Wang Y, O\u2019Neill S, Wu J, Omo-Lamai S, Espy C, Chase LS, Majumdar A, Hoffman E, Shah A, Sárközy A, Katzen J, Pardi N, Brenner JS |
2024 | |
Building a human lung from pluripotent stem cells to model respiratory viral infections
Turner DL, Amoozadeh S, Baric H, Stanley E, Werder RB |
Respiratory Research | 2024 |